Author
Listed:
- Michael Willem
(Biomedical Center (BMC), Ludwig-Maximilians-University Munich)
- Sabina Tahirovic
(German Center for Neurodegenerative Diseases (DZNE) Munich)
- Marc Aurel Busche
(Technische Universität München
Institute of Neuroscience, Technische Universität München
Munich Cluster for Systems Neurology (SyNergy), Ludwig-Maximilians-University Munich)
- Saak V. Ovsepian
(German Center for Neurodegenerative Diseases (DZNE) Munich)
- Magda Chafai
(Institut de Pharmacologie Moléculaire et Cellulaire (IPMC), Centre National de la Recherche Scientifique (CNRS), Université de Nice Sophia Antipolis)
- Scherazad Kootar
(Institut de Pharmacologie Moléculaire et Cellulaire (IPMC), Centre National de la Recherche Scientifique (CNRS), Université de Nice Sophia Antipolis)
- Daniel Hornburg
(Max Planck Institute of Biochemistry)
- Lewis D. B. Evans
(Gurdon Institute, University of Cambridge)
- Steven Moore
(Gurdon Institute, University of Cambridge)
- Anna Daria
(Biomedical Center (BMC), Ludwig-Maximilians-University Munich)
- Heike Hampel
(Biomedical Center (BMC), Ludwig-Maximilians-University Munich)
- Veronika Müller
(Biomedical Center (BMC), Ludwig-Maximilians-University Munich)
- Camilla Giudici
(Biomedical Center (BMC), Ludwig-Maximilians-University Munich)
- Brigitte Nuscher
(Biomedical Center (BMC), Ludwig-Maximilians-University Munich)
- Andrea Wenninger-Weinzierl
(German Center for Neurodegenerative Diseases (DZNE) Munich)
- Elisabeth Kremmer
(German Center for Neurodegenerative Diseases (DZNE) Munich
Munich Cluster for Systems Neurology (SyNergy), Ludwig-Maximilians-University Munich
Institute of Molecular Immunology, German Research Center for Environmental Health)
- Michael T. Heneka
(Clinical Neuroscience Unit, University of Bonn
German Center for Neurodegenerative Diseases (DZNE) Bonn)
- Dietmar R. Thal
(Institute of Pathology - Laboratory for Neuropathology, University of Ulm)
- Vilmantas Giedraitis
(Uppsala University)
- Lars Lannfelt
(Uppsala University)
- Ulrike Müller
(Institute for Pharmacy and Molecular Biotechnology IPMB, Functional Genomics, University of Heidelberg)
- Frederick J. Livesey
(Gurdon Institute, University of Cambridge)
- Felix Meissner
(Max Planck Institute of Biochemistry)
- Jochen Herms
(German Center for Neurodegenerative Diseases (DZNE) Munich)
- Arthur Konnerth
(Institute of Neuroscience, Technische Universität München
Munich Cluster for Systems Neurology (SyNergy), Ludwig-Maximilians-University Munich)
- Hélène Marie
(Institut de Pharmacologie Moléculaire et Cellulaire (IPMC), Centre National de la Recherche Scientifique (CNRS), Université de Nice Sophia Antipolis)
- Christian Haass
(Biomedical Center (BMC), Ludwig-Maximilians-University Munich
German Center for Neurodegenerative Diseases (DZNE) Munich
Munich Cluster for Systems Neurology (SyNergy), Ludwig-Maximilians-University Munich)
Abstract
A new pathway for the processing of β-amyloid precursor protein (APP) is described in which η-secretase activity, in part mediated by the MT5-MMP metalloproteinase, cleaves APP, and further processing by ADAM10 and BACE1 generates proteolytic fragments capable of inhibiting long-term potentiation in the hippocampus.
Suggested Citation
Michael Willem & Sabina Tahirovic & Marc Aurel Busche & Saak V. Ovsepian & Magda Chafai & Scherazad Kootar & Daniel Hornburg & Lewis D. B. Evans & Steven Moore & Anna Daria & Heike Hampel & Veronika M, 2015.
"η-Secretase processing of APP inhibits neuronal activity in the hippocampus,"
Nature, Nature, vol. 526(7573), pages 443-447, October.
Handle:
RePEc:nat:nature:v:526:y:2015:i:7573:d:10.1038_nature14864
DOI: 10.1038/nature14864
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:526:y:2015:i:7573:d:10.1038_nature14864. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.